{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Malvern",
      "address_1": "1400 Atwater Dr",
      "reason_for_recall": "Labeling: Incorrect Instructions: Dosage information on the immediate container label incorrectly states \"Two to four tablets four times daily.\" rather than the correct dosage of \"Two tablets three times daily.\"",
      "address_2": "",
      "product_quantity": "2,856 bottles",
      "code_info": "Lot #: 216702P1, Exp 09/20; 220409P1, Exp 01/21",
      "center_classification_date": "20181009",
      "distribution_pattern": "Nationwide in the USA.",
      "state": "PA",
      "product_description": "robaxin-750 (methocarbamol tablets, USP), 750 mg, 100-count bottle, Rx Only, Distributed by: Endo Pharmaceuticals Inc., Malvern, PA  19355; Manufactured by: Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannett Company, Inc., Seymour, IN  47274; NDC 52244-449-10.",
      "report_date": "20181010",
      "classification": "Class I",
      "openfda": {},
      "recalling_firm": "Endo Pharmaceuticals, Inc.",
      "recall_number": "D-0009-2019",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "81034",
      "termination_date": "20200204",
      "more_code_info": "",
      "recall_initiation_date": "20180917",
      "postal_code": "19355-8701",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}